[144] Phreesia, Inc. SEC Filing

Rhea-AI Filing Summary

Phreesia, Inc. submitted a Form 144 notice disclosing a proposed sale of 1,064 common shares through Fidelity Brokerage Services on 09/17/2025 with an aggregate market value of $25,004.00. The filing reports 59,914,473 shares outstanding. The 1,064 shares were acquired on 09/11/2025 under a restricted stock vesting arrangement and paid as compensation. The filing also lists multiple sales by Jessica Weiss and David Linetsky during the prior three months, including larger blocks by Mr. Linetsky (e.g., 23,729 shares for $676,195.48 on 06/27/2025). The notice includes the standard attestation that the seller does not possess undisclosed material adverse information.

Positive

• Required Rule 144 disclosures were filed, providing transparency about proposed insider sales.
• The shares to be sold were acquired via restricted stock vesting and are identified as compensation, clarifying the basis of acquisition.

Negative

• None.

Insights

Securities Analyst

TL;DR: Routine Form 144: small planned sale from recent restricted stock vesting and prior insider dispositions; disclosure supports market transparency.

The form documents a proposed sale of 1,064 common shares acquired via restricted stock vesting and designated as compensation. The filing also catalogs multiple insider sales over the past three months, notably several larger dispositions by David Linetsky totaling tens of thousands of shares. From a market-microstructure perspective, these are disclosed transactions required by Rule 144 and inform liquidity and float but represent a very small fraction of the reported 59,914,473 shares outstanding. No earnings, debt, or other operational metrics are presented.

Corporate Governance Expert

TL;DR: Governance processes appear followed: vested equity converted to sale notice and attestation provided; disclosures are standard.

The filing shows the company and insiders complying with Rule 144 disclosure requirements: the 1,064-share sale arises from restricted stock vesting and is marked as compensation, and the filer attests to absence of undisclosed material adverse information. Multiple prior sales by named insiders are listed with dates and gross proceeds, which is useful for oversight and shareholder transparency. The document contains no indication of governance disputes or unexplained transactions.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	1064	25004.00	59914473	09/17/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	09/11/2025	Restricted Stock Vesting	Issuer			1064	09/11/2025	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Jessica Weiss 1521 Concord Pike Suite 301 PMB 221 Wilmington DE 19803	Common	06/17/2025	42	1057.23
Jessica Weiss 1521 Concord Pike Suite 301 PMB 221 Wilmington DE 19803	Common	06/18/2025	67	1715.96
David Linetsky 1521 Concord Pike Suite 301 PMB 221 Wilmington DE 19803	Common	06/27/2025	23729	676195.48
David Linetsky 1521 Concord Pike Suite 301 PMB 221 Wilmington DE 19803	Common	07/17/2025	2063	55465.41
Jessica Weiss 1521 Concord Pike Suite 301 PMB 221 Wilmington DE 19803	Common	08/18/2025	78	2274.13
David Linetsky 1521 Concord Pike Suite 301 PMB 221 Wilmington DE 19803	Common	08/22/2025	17445	518681.81
Jessica Weiss 1521 Concord Pike Suite 301 PMB 221 Wilmington DE 19803	Common	09/16/2025	114	2654.42
David Linetsky 1521 Concord Pike Suite 301 PMB 221 Wilmington DE 19803	Common	09/16/2025	2051	47756.30

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does Phreesia's (PHR) Form 144 filed on this document disclose?

The Form 144 discloses a proposed sale of 1,064 common shares via Fidelity on 09/17/2025 with an aggregate market value of $25,004.00.

How were the 1,064 shares acquired according to the filing?

The shares were acquired on 09/11/2025 through restricted stock vesting and the payment nature is listed as compensation.

How many shares outstanding does the filing report for Phreesia?

The filing reports 59,914,473 shares outstanding.

Did insiders sell shares in the three months before this filing?

Yes; the filing lists multiple insider sales, including David Linetsky selling 23,729 shares for $676,195.48 on 06/27/2025 and other transactions by Jessica Weiss and Mr. Linetsky through 09/16/2025.

Does the filer attest to possession of material nonpublic information?

The signed notice includes the attestation that the person does not know any material adverse information about the issuer that has not been publicly disclosed.